Economic evidence in stroke: A review

European Journal of Health Economics

Volumn 5, Issue SUPPL. 1, 2004, Pages

  Ekman, Mattias ^a  

^a STOCKHOLM HEALTH ECONOMICS   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ABSENTEEISM; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COST OF ILLNESS; DRUG COST; ECONOMIC EVALUATION; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; INVESTMENT; LENGTH OF STAY; MEDICAL LITERATURE; MEDLINE; MONEY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RETIREMENT; REVIEW; STROKE; SURVIVAL RATE; TRANSIENT ISCHEMIC ATTACK;

ACTUARIAL ANALYSIS; CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; EUROPE; HUMANS;

EID: 7444255962     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-005-0292-3     Document Type: Review

References (30)

1. Sundberg G, Bagust A, Terent A (2003) A model for costs of stroke services. Health Policy 63:81-94
2. Stegmayr B, Asplund K (2003) Stroke in Northern Sweden. Scand J Public Health Suppl 61:60-69
3. Kaste M, Fogelholm R, Rissanen A (1998) Economic burden of stroke and the evaluation of new therapies. Public Health 112:103-112
4. Bradberry JC, Fagan SC, Gray DR, Moon YS (2004) New perspectives on the pharmacotherapy of ischemic stroke. J Am Pharm Assoc (Wash DC) 44: S46-56; quiz S56-47
5. Sudlow CL, Warlow CP (1997) Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28:491-499
6. Henriksson F, Fredrikson S, Masterman T, Jonsson B (2001) Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neural 8:27-35
7. Hodgson TA, Meiners MR (1982) Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 60:429-462
8. Luce BR, Elixhauser A (1990) Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care 6:57-75
9. Payne KA, Huybrechts KF, Caro JJ, Craig Green TJ, Klittich WS (2002) Long term cost-of-illness in stroke: an international review. Pharmacoeconomics 20:813-825
10. Porsdal V, Boysen G (1997) Cost-of-illness studies of stroke. Cerebrovasc Dis 7:258-263
11. Levy E, Gabriel S, Dinet J (2003) The comparative medical costs of atherothrombotic disease in European countries. Pharmacoeconomics 21:651-659
12. Spieler JF, Lanoe JL, Amarenco P (2002) Socioeconomic aspects of postacute care for patients with brain infarction in France. Cerebrovasc Dis 13:132-141
13. Weimar C, Weber C, Wagner M, Busse O, Haberl RL, Lauterbach KW, Diener HC (2003) Management patterns and health care use after intracerebral hemorrhage, a cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 15:29-36
14. Bergman L, van der Meulen JH, Limburg M, Habbema JD (1995) Costs of medical care after first-ever stroke in The Netherlands. Stroke 26:1830-1836
15. Van Exel J, Koopmanschap MA, Van Wijngaarden JD, Scholte Op Reimer WJ (2003) Costs of stroke and stroke services: determinants of patient costs and a comparison of costs of regular care and care organised in stroke services. Cost Eff Resour Alloc 1:2
16. Carod-Artal FJ, Egido-Navarro JA, Gonzalez-Gutierrez JL, Varela de Seijas E (1999) Direct cost of cerebrovascular disease during the first year of follow-up. Rev Neural 28:1123-1130
17. Porsdal V, Boysen G (1999) Costs of health care and social services during the first year after ischemic stroke, Int J Technol Assess Health Care 15:573-584
18. Porsdal V, Boysen G (1999) Direct costs during the first year after intracerebral hemorrhage. Eur J Neurol 6:449-454
19. Porsdal V, Boysen G (1998) Direct costs of transient ischemic attacks: a hospital-based study of resource use during the first year after transient ischemic attacks in Denmark. Stroke 29:2321-2324
20. Zethraeus N, Molin T, Henriksson P, Jonsson B (1999) Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 246:151-159
21. Claesson L, Gosman-Hedstrom G, Johannesson M, Fagerberg B, Blomstrand C (2000) Resource utilization and costs of stroke unit care integrated in a care continuum: A 1-year controlled, prospective, randomized study in elderly patients: The Goteborg 70+ Stroke Study. Stroke 31:2569-2577
22. Gosman-Hedstrom G, Claesson L, Blomstrand C (2002) Use and cost of assistive technology the first year after stroke. A randomized controlled trial. Int J Technol Assess Health Care 18(3):520-527
23. Andersson A, Levin LA, Oberg B, Mansson L (2002) Health care and social welfare costs in home-based and hospital-based rehabilitation after stroke. Scand J Caring Sci 16:386-392
24. Persson U, Silverberg R, Lindgren B, Norrving B, Jadback G, Johansson B, Puranen BI (1990) Direct costs of stroke for a Swedish population. Int J Technol Assess Health Care 6:125-137
25. Terent A, Marke LA, Asplund K, Norrving B, Jonsson E, Wester PO (1994) Costs of stroke in Sweden. A national perspective. Stroke 25:2363-2369
26. Grieve R, Hutton J, Bhalla A, Rastenyte D, Ryglewicz D, Sarti C, Lamassa M, Giroud M, Dundas R, Wolfe CD (2001) A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke 32:1684-1691
27. Hannerz H, Nielsen M (2001) Life expectancies among survivors of acute cerebrovascular disease. Stroke 32(8):1739-1744
28. Post PN, Stiggelbout AM, Wakker PP (2001) The utility of health states after stroke: a systematic review of the literature. Stroke 32:1425-1429
29. Tengs TO, Yu M, Luistro E (2001) Health-related quality of life after stroke a comprehensive review. Stroke 32:964-972
30. Tengs TO, Lin TH (2003) A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics 21:191-200